Sauce Labs was founded in 2008 by Al Sargent, Jason Huggins, John Dunham, and Steven Hazel. The company has not publicly endorsed plans to participate in an IPO.
Sauce Labs offers continuous testing solutions for companies and developers, giving businesses the tools to make sure that their websites and applications are functioning properly at all times. The company has acquired six companies since 2016, including Backtrace, TestFairy, AutonomIQ, and API Fortress. Sauce Labs has raised more than $150 million in venture capital funding from investors including IVP, Centerview Capital, Adams Street Partners, TPG, and Riverwood Capital. The company has not released valuation statistics.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/26/2019 | Series F | $50MM | $xx.xx | $61.31B | Riverwood Capital, Tpg | |
Price per Share
$xx.xx
Shares Outstanding
39,862,872
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Riverwood Capital, Tpg
|
||||||
11/15/2016 | Series CE | $4.33MM | $xx.xx | $23.5B | Adam Street Partners, Centerview Capital Technology, Ivp | |
Price per Share
$xx.xx
Shares Outstanding
7,647,910
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Centerview Capital Technology, Ivp
|
||||||
11/15/2016 | Series AE | $15.67MM | $xx.xx | $23.5B | Adam Street Partners, Centerview Capital Technology, Ivp | |
Price per Share
$xx.xx
Shares Outstanding
27,713,616
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Centerview Capital Technology, Ivp
|
||||||
11/15/2016 | Series BE | $18.15MM | $xx.xx | $23.5B | Adam Street Partners, Centerview Capital Technology, Ivp | |
Price per Share
$xx.xx
Shares Outstanding
32,086,817
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Centerview Capital Technology, Ivp
|
||||||
11/15/2016 | Series E | $33.39MM | $xx.xx | $23.5B | Adam Street Partners, Centerview Capital Technology, Ivp | |
Price per Share
$xx.xx
Shares Outstanding
59,028,703
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Centerview Capital Technology, Ivp
|
||||||
02/05/2015 | Series D | $16.63MM | $xx.xx | $9.41B | Toba Capital | |
Price per Share
$xx.xx
Shares Outstanding
36,188,178
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Toba Capital
|
||||||
06/30/2014 | Series C-1 | $5MM | $xx.xx | $5.05B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
15,595,757
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
07/16/2013 | Series C | $5MM | $xx.xx | $3.14B | Scott Banister, Toba Capita, Triage Ventures | |
Price per Share
$xx.xx
Shares Outstanding
22,643,798
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Scott Banister, Toba Capita, Triage Ventures
|
||||||
08/28/2012 | Series B | $3.04MM | $xx.xx | $1.26B | Salesforce, Triage Ventures | |
Price per Share
$xx.xx
Shares Outstanding
25,936,584
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Salesforce, Triage Ventures
|
||||||
07/29/2009 | Series A | $1.16MM | $xx.xx | $1.89B | The Contrarian Group | |
Price per Share
$xx.xx
Shares Outstanding
10,750,882
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
The Contrarian Group
|
||||||
07/29/2009 | Series A-3 | $3.94MM | $xx.xx | $1.89B | The Contrarian Group | |
Price per Share
$xx.xx
Shares Outstanding
11,701,606
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
The Contrarian Group
|